Genprex, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Genprex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Genprex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $242.88K, a 68.19% decline year-over-year.
- Genprex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $110.70K.
- Genprex, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $324.33K.
- Genprex, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $677.91K, a 48.65% decline from fiscal 2020.
- Genprex, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $1.32M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $677.91K 10-K · filed 2023-03-31 |
| 2021-09-30 | $242.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.17M derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | $110.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.69M derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | $324.33K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $495.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.32M 10-K · filed 2022-03-30 |
| 2020-09-30 | $763.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |